Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index. Rheumatology (Oxford). 2018 01 01; 57(1):125-133.
View in:
PubMed
subject areas
Adrenal Cortex Hormones
Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
B-Cell Activating Factor
B-Cell Activating Factor
Clinical Trials as Topic
Clinical Trials as Topic
Clinical Trials, Phase III as Topic
Clinical Trials, Phase III as Topic
Drug Therapy, Combination
Drug Therapy, Combination
Humans
Humans
Immunosuppressive Agents
Immunosuppressive Agents
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Medication Adherence
Medication Adherence
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
Treatment Outcome
authors with profiles
Joan Merrill